{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:27:08Z","timestamp":1792783628002,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grants-in-Aid for Scientific Research program of the Japanese Ministry of Education, Culture, Sports, Science, and Technology","award":["19K10311"],"award-info":[{"award-number":["19K10311"]}],"id":[{"id":"https:\/\/ror.org\/048rj2z13","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10753-020-01322-w","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T22:02:21Z","timestamp":1596924141000},"page":"206-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-\u03b3-Induced CXCL10 Production in Human Salivary Gland Ductal Cells"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5413-5750","authenticated-orcid":false,"given":"Keiko","family":"Aota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yamanoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Momota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,9]]},"reference":[{"key":"1322_CR1","first-page":"971","volume-title":"Textbook of Rheumatology","author":"MA Alspaugh","year":"1981","unstructured":"Alspaugh, M.A., and K. Whaley. 1981. Sj\u00f6gren\u2019s syndrome. In Textbook of Rheumatology, ed. W.N. Kelley, E.D. Harris, S. Ruddy, and C.B. Sledge, 971\u2013999. Philadelphia: Saunders (imprint)."},{"key":"1322_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","volume":"203","author":"FB Vivino","year":"2019","unstructured":"Vivino, F.B., V.Y. Bunya, G. Massaro-Giordano, C.R. Johr, S.L. Giattino, A. Schorpion, B. Shafer, A. Peck, K. Sivils, A. Rasmussen, J.A. Chiorini, J. He, and J.L. Ambrus Jr. 2019. Sj\u00f6gren\u2019s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clinical Immunology 203: 81\u2013121.","journal-title":"Clinical Immunology"},{"key":"1322_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/art.1780270205","volume":"27","author":"TE Daniel","year":"1984","unstructured":"Daniel, T.E. 1984. Labial salivary gland biopsy in Sj\u00f6gren\u2019s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis and Rheumatism 27: 147\u2013156.","journal-title":"Arthritis and Rheumatism"},{"key":"1322_CR4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"MI Christodoulou","year":"2010","unstructured":"Christodoulou, M.I., E.K. Kapsogeorgou, and H.M. Moutsopoulos. 2010. Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome. Journal of Autoimmunity 34: 400\u2013407.","journal-title":"Journal of Autoimmunity"},{"key":"1322_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5114\/reum.2019.83237","volume":"57","author":"B Kami\u0144ski","year":"2019","unstructured":"Kami\u0144ski, B. 2019. Laryngological manifestations of Sj\u00f6gren\u2019s syndrome. Reumatologia 57: 37\u201344.","journal-title":"Reumatologia"},{"key":"1322_CR6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","volume":"9","author":"G Nocturne","year":"2013","unstructured":"Nocturne, G., and X. Mariette. 2013. Advances in understanding the pathogenesis of primary Sj\u00f6gren\u2019s syndrome. Nature Reviews. Rheumatology 9: 544\u2013556.","journal-title":"Nature Reviews. Rheumatology"},{"key":"1322_CR7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","volume":"72","author":"Z Brkic","year":"2013","unstructured":"Brkic, Z., N.I. Maria, C.G. van Helden-Meeuwsen, J.P. van de Merwe, P.L. van Daele, V.A. Dalm, M.E. Wildenberg, W. Beumer, H.A. Drexhage, and M.A. Versnel. 2013. Prevalence of interferon type I signature in CD14 monocytes of patients with Sj\u00f6gren\u2019s syndrome and association with disease activity and BAFF gene expression. Annals of the Rheumatic Diseases 72: 728\u2013735.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1322_CR8","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.21006","volume":"52","author":"TO Hjelmervik","year":"2005","unstructured":"Hjelmervik, T.O., K. Petersen, I. Jonassen, R. Jonsson, and A.I. Bolstad. 2005. Gene expression profiling of minor salivary glands clearly distinguishes primary Sj\u00f6gren\u2019s syndrome patients from healthy control subjects. Arthritis and Rheumatism 52: 1534\u20131544.","journal-title":"Arthritis and Rheumatism"},{"key":"1322_CR9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/ard.2006.063370","volume":"66","author":"E Wakamatsu","year":"2007","unstructured":"Wakamatsu, E., Y. Nakamura, I. Matsumoto, D. Goto, S. Ito, A. Tsutsumi, and T. Sumida. 2007. DNA Microarray Analysis of Labial Salivary Glands of Patients With Sj\u00f6gren\u2019s Syndrome. Annals of the Rheumatic Diseases 66: 844\u2013845.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1322_CR10","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","volume":"75","author":"J Imgenberg-Kreuz","year":"2016","unstructured":"Imgenberg-Kreuz, J., J.K. Sandling, J.C. Alml\u00f6f, J. Nordlund, L. Sign\u00e9r, K.B. Norheim, R. Omdal, L. R\u00f6nnblom, M.L. Eloranta, A.C. Syv\u00e4nen, and G. Nordmark. 2016. Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren\u2019s syndrome reveals regulatory effects at interferon-induced genes. Annals of the Rheumatic Diseases 75: 2029\u20132036.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1322_CR11","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/art.39204","volume":"67","author":"JC Hall","year":"2015","unstructured":"Hall, J.C., A.N. Baer, A.A. Shah, L.A. Criswell, C.H. Shiboski, A. Rosen, and L. Casciola-Rosen. 2015. Molecular subsetting of interferon pathways in Sj\u00f6gren\u2019s syndrome. Arthritis and Rheumatology 67: 2437\u20132446.","journal-title":"Arthritis and Rheumatology"},{"key":"1322_CR12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/315672a0","volume":"315","author":"AD Luster","year":"1985","unstructured":"Luster, A.D., J.C. Unkeless, and J.V. Ravetch. 1985. \u03b3-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315: 672\u2013676.","journal-title":"Nature"},{"key":"1322_CR13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli, A., S.M. Ferrari, D. Giuggioli, E. Ferrannini, C. Ferri, and P. Fallahi. 2014. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmunity Reviews 13: 272\u2013280.","journal-title":"Autoimmunity Reviews"},{"key":"1322_CR14","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/art.10577","volume":"46","author":"N Ogawa","year":"2002","unstructured":"Ogawa, N., L. Ping, L. Zhenjun, Y. Takada, and S. Sugai. 2002. Involvement of the interferon-\u03b3-induced T cell-attracting chemokines, interferon-\u03b3-inducible 10-kd protein (CXCL10) and monokine induced by interferon-\u03b3 (CXCL9), in the salivary gland lesions of patients with Sj\u00f6gren\u2019s syndrome. Arthritis and Rheumatism 46: 2730\u20132741.","journal-title":"Arthritis and Rheumatism"},{"key":"1322_CR15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/jop.12756","volume":"47","author":"K Aota","year":"2018","unstructured":"Aota, K., T. Yamanoi, K. Kani, K.I. Nakashiro, N. Ishimaru, and M. Azuma. 2018. Inverse correlation between the number of CXCR3+ macrophages and the severity of inflammatory lesions in Sj\u00f6gren\u2019s syndrome salivary glands: A pilot study. Journal of Oral Pathology and Medicine 47: 710\u2013718.","journal-title":"Journal of Oral Pathology and Medicine"},{"key":"1322_CR16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s10753-018-0764-0","volume":"41","author":"K Aota","year":"2018","unstructured":"Aota, K., K. Kani, T. Yamanoi, K.I. Nakashiro, N. Ishimaru, and M. Azuma. 2018. Distinct regulation of CXCL10 production by cytokines in human salivary gland ductal and acinar cells. Inflammation 41: 1172\u20131181.","journal-title":"Inflammation"},{"key":"1322_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","volume":"16","author":"WJ Leonard","year":"1998","unstructured":"Leonard, W.J., and J.J. O\u2019Shea. 1998. Jaks and STATs: Biological implications. Annual Review of Immunology 16: 293\u2013322.","journal-title":"Annual Review of Immunology"},{"key":"1322_CR18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/13543784.2019.1631796","volume":"28","author":"S Pringle","year":"2019","unstructured":"Pringle, S., X. Wang, H. Bootsma, F.K.L. Spijkervet, A. Vissink, and F.G.M. Kroese. 2019. Small-molecule inhibitors and the salivary gland epithelium in Sj\u00f6gren\u2019s syndrome. Expert Opinion on Investigational Drugs 28: 605\u2013616.","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"1322_CR19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/1744666X.2016.1214576","volume":"12","author":"S Kubo","year":"2016","unstructured":"Kubo, S., S. Nakayamada, and Y. Tanaka. 2016. Baricitinib for the treatment of rheumatoid arthritis. Expert Review of Clinical Immunology 12: 911\u2013919.","journal-title":"Expert Review of Clinical Immunology"},{"issue":"376","key":"1322_CR20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","volume":"16","author":"PC Taylor","year":"2017","unstructured":"Taylor, P.C., E.C. Keystone, D. van der Heijde, M.E. Weinblatt, L. Del Carmen MoralesL, J. Reyes Gonzaga, S. Yakushin, T. Ishii, K. Emoto, S. Beattie, V. Arora, C. Gaich, T. Rooney, D. Schlichting, W.L. Macias, S. de Bono, and Y. Tanaka. 2017. Baricitinib versus Placebo or adalimumab in rheumatoid arthritis. The New England Journal of Medicine 16 (376): 652\u2013662.","journal-title":"The New England Journal of Medicine"},{"key":"1322_CR21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/s10165-004-0338-x","volume":"14","author":"T Fujibayashi","year":"2004","unstructured":"Fujibayashi, T., S. Sugai, N. Miyasaka, Y. Hayashi, and K. Tsubota. 2004. Revised Japanese criteria for Sj\u00f6gren\u2019s syndrome (1999): Availability and validity. Modern Rheumatology 14: 425\u2013434.","journal-title":"Modern Rheumatology"},{"key":"1322_CR22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski, S.C., C.H. Shiboski, L.A. Criswell, A.N. Baer, S. Challacombe, H. Lanfranchi, M. Schi\u00f8dt, H. Umehara, F. Vivino, Y. Zhao, Y. Dong, D. Greenspan, A.M. Heidenreich, P. Helin, B. Kirkham, K. Kitagawa, G. Larkin, M. Li, T. Lietman, J. Lindegaard, N. McNamara, K. Sack, P. Shirlaw, S. Sugai, C. Vollenweider, J. Whitcher, A. Wu, S. Zhang, W. Zhang, J.S. Greenspan, and T.E. Daniels for the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance (SICCA) Research Groups. 2012. American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: A data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care and Research 64: 475\u2013487.","journal-title":"Arthritis Care and Research"},{"key":"1322_CR23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0030-4220(74)90160-1","volume":"37","author":"TM Tarpley Jr","year":"1974","unstructured":"Tarpley, T.M., Jr., L.G. Anderson, and C.L. White. 1974. Minor salivary gland involvement in Sj\u00f6gren\u2019s syndrome. Oral Surgery, Oral Medicine, and Oral Pathology 37: 64\u201374.","journal-title":"Oral Surgery, Oral Medicine, and Oral Pathology"},{"key":"1322_CR24","first-page":"24","volume":"69","author":"M Azuma","year":"1993","unstructured":"Azuma, M., T. Tamatani, Y. Kasai, and M. Sato. 1993. Immortalization of normal human salivary gland cells with duct-, myoepithelial-, acinar-, or squamous phenotype by transfection with SV40 ori- mutant deoxyribonucleic acid. Laboratory Investigation 69: 24\u201342.","journal-title":"Laboratory Investigation"},{"key":"1322_CR25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/gb-2004-5-12-253","volume":"5","author":"K Yamaoka","year":"2004","unstructured":"Yamaoka, K., P. Saharinen, M. Pesu, V.E. Holt 3rd, O.J. Silvennoinen, and J.J. O\u2019Shea. 2004. The Janus Kinases (Jaks). Genome Biology 5: 253.","journal-title":"Genome Biology"},{"key":"1322_CR26","doi-asserted-by":"publisher","unstructured":"Fox, R.I., C.M. Fox, J.E. Gottenberg, and T. D\u00f6rner. 2019. Treatment of Sj\u00f6gren\u2019s syndrome: current therapy and future directions. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/kez142.","DOI":"10.1093\/rheumatology\/kez142"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-020-01322-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-020-01322-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-020-01322-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T19:22:02Z","timestamp":1628450522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-020-01322-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1007\/s10753-020-01322-w","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,9]]},"assertion":[{"value":"9 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of Tokushima University Hospital (#2802) and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study, and this process was documented by the Institutional Review Board of Tokushima University Hospital. The informed consent procedure was approved by the Ethics Committee of Tokushima University Hospital.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Authorization has been given from all authors to use unpublished data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}